Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-17

Clinical Trial Update: Cold Contact Urticaria Treatment With Rilonacept [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rilonacept for cold contact urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rilonacept (rilonacept)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Cold Contact Urticaria | Phase 2 | Status: COMPLETED